CN115385871A - 舒欣啶盐 - Google Patents

舒欣啶盐 Download PDF

Info

Publication number
CN115385871A
CN115385871A CN202211089980.8A CN202211089980A CN115385871A CN 115385871 A CN115385871 A CN 115385871A CN 202211089980 A CN202211089980 A CN 202211089980A CN 115385871 A CN115385871 A CN 115385871A
Authority
CN
China
Prior art keywords
salt
peaks
xrpd pattern
crystalline
suxindine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211089980.8A
Other languages
English (en)
Chinese (zh)
Inventor
苏珊妮·J·罗马诺
海莉·安·里斯
约瑟夫·爱德华·戈登·本森
莎拉·柯林斯
加里·T·艾略特
米雷耶·吉林斯
罗伯特·古德诺
柯蒂斯·泰里
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huya Biological International Co ltd
Original Assignee
Huya Biological International Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huya Biological International Co ltd filed Critical Huya Biological International Co ltd
Publication of CN115385871A publication Critical patent/CN115385871A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/42—Separation; Purification; Stabilisation; Use of additives
    • C07C303/44—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/05—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing at least two sulfo groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
CN202211089980.8A 2019-01-29 2020-01-28 舒欣啶盐 Pending CN115385871A (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201962798467P 2019-01-29 2019-01-29
US62/798,467 2019-01-29
US202062959687P 2020-01-10 2020-01-10
US62/959,687 2020-01-10
PCT/US2020/015370 WO2020159959A1 (en) 2019-01-29 2020-01-28 Sulcardine salts
CN202080004796.1A CN112638903B (zh) 2019-01-29 2020-01-28 舒欣啶盐

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN202080004796.1A Division CN112638903B (zh) 2019-01-29 2020-01-28 舒欣啶盐

Publications (1)

Publication Number Publication Date
CN115385871A true CN115385871A (zh) 2022-11-25

Family

ID=69724142

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202211089980.8A Pending CN115385871A (zh) 2019-01-29 2020-01-28 舒欣啶盐
CN202080004796.1A Active CN112638903B (zh) 2019-01-29 2020-01-28 舒欣啶盐

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202080004796.1A Active CN112638903B (zh) 2019-01-29 2020-01-28 舒欣啶盐

Country Status (16)

Country Link
US (3) US11426382B2 (https=)
EP (1) EP3917921A1 (https=)
JP (3) JP2022518906A (https=)
KR (2) KR102405199B1 (https=)
CN (2) CN115385871A (https=)
AU (1) AU2020216925B2 (https=)
BR (1) BR112021014640A8 (https=)
CA (1) CA3128152A1 (https=)
CL (1) CL2021001968A1 (https=)
CO (1) CO2021011042A2 (https=)
IL (1) IL285184B2 (https=)
MX (2) MX2021009033A (https=)
PH (1) PH12021551818A1 (https=)
SG (1) SG11202108160YA (https=)
WO (1) WO2020159959A1 (https=)
ZA (2) ZA202105344B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11364223B2 (en) 2018-12-13 2022-06-21 Huyabio International, Llc Sulcardine administration for treatment of acute atrial fibrillation
CN115385871A (zh) * 2019-01-29 2022-11-25 沪亚生物国际有限公司 舒欣啶盐
CA3182015A1 (en) 2020-06-12 2021-12-16 Gary Elliott Sulcardine administration for treatment of acute atrial fibrillation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605635B1 (en) * 1999-12-10 2003-08-12 Shanghai Institute Of Materia Medica Chinese Academy Of Science N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof
CN102869357A (zh) * 2009-11-17 2013-01-09 沪亚生物国际有限责任公司 舒欣啶及其盐的缓慢滴注

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1299813C (zh) 2004-12-28 2007-02-14 华南理工大学 自动撕膜落料及多样性搅拌的机构和控制装置
CN1939298A (zh) * 2005-09-29 2007-04-04 中国科学院上海药物研究所 硫酸舒欣啶固体和靶向制剂及其制备方法
CN102665714A (zh) 2009-11-17 2012-09-12 沪亚生物国际有限责任公司 心房纤颤的治疗
MA41599A (fr) * 2015-02-26 2018-01-02 Array Biopharma Inc Formes cristallines d'un composé pyrrolopyridine
CA3254279A1 (en) 2015-06-03 2025-03-18 Triastek, Inc. PHARMACEUTICAL FORMS AND RELATED USES
CA3023278C (en) 2016-05-05 2019-04-30 Triastek, Inc. Controlled release dosage form
KR20190107712A (ko) 2017-01-26 2019-09-20 트리아스텍 인코포레이티드 특정 위장 부위에서의 제어 방출의 투여 형태
CA3054403A1 (en) * 2017-02-24 2018-08-30 Gilead Sciences, Inc. Inhibitors of bruton's tyrosine kinase
US11364223B2 (en) 2018-12-13 2022-06-21 Huyabio International, Llc Sulcardine administration for treatment of acute atrial fibrillation
CN115385871A (zh) 2019-01-29 2022-11-25 沪亚生物国际有限公司 舒欣啶盐

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605635B1 (en) * 1999-12-10 2003-08-12 Shanghai Institute Of Materia Medica Chinese Academy Of Science N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof
CN102869357A (zh) * 2009-11-17 2013-01-09 沪亚生物国际有限责任公司 舒欣啶及其盐的缓慢滴注

Also Published As

Publication number Publication date
BR112021014640A8 (pt) 2022-12-20
US20200316024A1 (en) 2020-10-08
PH12021551818A1 (en) 2022-03-28
KR102405199B1 (ko) 2022-06-02
AU2020216925B2 (en) 2022-09-15
ZA202105344B (en) 2023-01-25
KR20220079688A (ko) 2022-06-13
KR102697726B1 (ko) 2024-08-21
AU2020216925A1 (en) 2021-09-02
IL285184A (en) 2021-09-30
BR112021014640A2 (pt) 2021-09-21
US20250144072A9 (en) 2025-05-08
US11426382B2 (en) 2022-08-30
CL2021001968A1 (es) 2022-01-28
ZA202107474B (en) 2022-06-29
JP2024039020A (ja) 2024-03-21
IL285184B2 (en) 2023-12-01
IL285184B1 (en) 2023-08-01
EP3917921A1 (en) 2021-12-08
US20210038568A1 (en) 2021-02-11
US11020374B2 (en) 2021-06-01
KR20210130157A (ko) 2021-10-29
JP2022518906A (ja) 2022-03-17
US20220356319A1 (en) 2022-11-10
CO2021011042A2 (es) 2022-01-17
MX2023014776A (es) 2024-01-15
JP2025165933A (ja) 2025-11-05
WO2020159959A1 (en) 2020-08-06
CN112638903B (zh) 2022-08-26
CA3128152A1 (en) 2020-08-06
CN112638903A (zh) 2021-04-09
MX2021009033A (es) 2021-10-13
SG11202108160YA (en) 2021-08-30

Similar Documents

Publication Publication Date Title
JP2024039020A (ja) サルカルディン塩
JP2016513678A (ja) 複素環式化合物及びそれらの使用
JP2023550428A (ja) インテグリン阻害剤およびその使用
US20250074878A1 (en) Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US20240208931A1 (en) Solid state forms of (s)-n-(3-(2-(((r)-1-hydroxypropan-2-yl)amino)-6-morpholinopyridin-4-yl)-4-methylphenyl)-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and salts thereof
ES2651689T3 (es) Forma salina de alfa-6-mPEG6-O-hidroxicodona sólida como antagonista opioide y usos de la misma
CN116056711B (zh) 吡啶-3-甲酸2-[4-[(2,3,4-三甲氧基苯基)甲基]哌嗪-1-基]乙酯的晶体形式和合成方法
HK40079384A (en) Sulcardine salts
HK40049638B (en) Sulcardine salts
HK40049638A (en) Sulcardine salts
EA043571B1 (ru) Соли сулькардина
TWI898321B (zh) 用於治療或預防高尿酸血症或痛風的化合物的固體晶型
BR112021002200A2 (pt) sal erbumina de trepostinila
BR112013008664B1 (pt) Forma cristalina ii de [cloridrato de 4-metilbenzoato de 4-[2-dimetilamino-1-(1-hidroxiciclohexil)etil]fenila], seus métodos de preparação e seu uso, e composição farmacêutica
JP2025530060A (ja) 高尿酸血症または痛風を治療若しくは予防するための化合物の固体結晶形
BR112019015487A2 (pt) Formas cristalinas de tebipenem pivoxil, composições incluindo as mesmas, métodos de fabricação e métodos de uso

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40079384

Country of ref document: HK

WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20221125

WD01 Invention patent application deemed withdrawn after publication